These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29503420)

  • 1. [Risk/Benefit Communication: International Developments and Prospects for the Future].
    Yamamoto M
    Yakugaku Zasshi; 2018; 138(3):299-306. PubMed ID: 29503420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safe Use of Recent New Drugs-Current Status and Challenges].
    Ohashi Y
    Yakugaku Zasshi; 2018; 138(2):177-183. PubMed ID: 29386431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Pharmaceuticals and Medical Devices Agency's Approach to Facilitate Risk Communication and Its Challenges].
    Kondo E; Torii M; Oba I; Okamoto M
    Yakugaku Zasshi; 2018; 138(3):307-314. PubMed ID: 29503421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Making Patient-focused Information Provision a Reality: One Company's Approach].
    Takemoto S
    Yakugaku Zasshi; 2018; 138(3):315-323. PubMed ID: 29503422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk communication efforts regarding drug safety in the US and EU, and Japan].
    Yamamoto M
    Yakugaku Zasshi; 2012; 132(5):533-48. PubMed ID: 22687688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Communication and the Pharmaceutical Industry: what is the reality?
    Edwards B; Chakraborty S
    Drug Saf; 2012 Nov; 35(11):1027-40. PubMed ID: 23061779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions.
    Pignatti F; Ashby D; Brass EP; Eichler HG; Frey P; Hillege HL; Hori A; Levitan B; Liberti L; Löfstedt RE; McAuslane N; Micaleff A; Noel RA; Postmus D; Renn O; Sabourin BJ; Salmonson T; Walker S
    Clin Pharmacol Ther; 2015 Nov; 98(5):522-33. PubMed ID: 26261064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of rapid drug safety communication materials for patients in Japan.
    Yaguchi-Saito A; Yamamoto K; Sengoku T; Suka M; Sato T; Hinata M; Nakamura T; Nakayama T; Yamamoto M
    Drug Discov Ther; 2021 May; 15(2):101-107. PubMed ID: 33952763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of risk management and risk assessment information: the role of the pharmacist.
    Schommer JC; Pedersen CA; Worley MM; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL; Chewning BA
    Res Social Adm Pharm; 2006 Dec; 2(4):458-78. PubMed ID: 17161806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations.
    Molimard M; Bernaud C; Lechat P; ; Bejan-Angoulvant T; Benattia C; Benkritly A; Braunstein D; Cabut S; David N; Fourrier-Réglat A; Gallet B; Gersberg M; Goni S; Jolliet P; Lamarque-Garnier V; Le Jeunne C; Leurs I; Liard F; Malbezin M; Micallef J; Nguon M
    Therapie; 2014; 69(4):355-66. PubMed ID: 25099666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving communication of drug risks to prevent patient injury: proceedings of a workshop.
    Campbell WH; Califf RM
    Pharmacoepidemiol Drug Saf; 2003; 12(3):183-94. PubMed ID: 12733471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-risk communication to pharmacists: assessing the impact of risk-minimization strategies on the practice of pharmacy.
    Lee LY; Kortepeter CM; Willy ME; Nourjah P
    J Am Pharm Assoc (2003); 2008; 48(4):494-500. PubMed ID: 18653425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communication of medical product risk: how effective is effective enough?
    Goldman SA
    Drug Saf; 2004; 27(8):519-34. PubMed ID: 15154825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.
    Way D; Blazsin H; Löfstedt R; Bouder F
    Drug Saf; 2017 Jan; 40(1):15-36. PubMed ID: 27743334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory agencies, pharmaceutical information and the Internet: a European perspective.
    Bauschke R
    Health Policy; 2012 Jan; 104(1):12-8. PubMed ID: 22101089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.